Conrad Wai - 14 Sep 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO, Counterpart Health
Signature
/s/ Peter J. Rivas as attorney-in-fact for Conrad Wai
Issuer symbol
CLOV
Transactions as of
14 Sep 2025
Net transactions value
-$301,141
Form type
4
Filing time
16 Sep 2025, 16:19:10 UTC
Previous filing
04 Aug 2025
Next filing
17 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wai Conrad CEO, Counterpart Health C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai 16 Sep 2025 0001971702

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability $301,141 -98,412 -5.9% $3.06 1,573,425 14 Sep 2025 Direct F1
holding CLOV Class A Common Stock 1,403,701 14 Sep 2025 By Trust. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.
F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.